European Respiratory Society, 2023
EFZO-FIT™: A Phase 3 Study of Efzofitimod, a Novel Immunomodulator for the Treatment of Pulmonary Sarcoidosis
World Association for Sarcoidosis and Other Granulomatous Disorders, 2023
Identification of Key Fibrotic Extracellular Targets for Alanyl- and Aspartyl-tRNA Synthetases
International Symposium of Aminoacyl-tRNA Synthetases, 2023
Circulating His-tRNA Synthetase is Reduced in Patients Harboring the Usher Syndrome Type 3B-Linked Mutation Y454S
International Symposium of Aminoacyl-tRNA Synthetases, 2023
Exposure-Efficacy Analysis Supports Proof of Concept for Efzofitimod in Pulmonary Sarcoidosis
American Thoracic Society, 2023
Efzofitimod, a Novel Immunomodulator for Pulmonary Sarcoidosis, Modulates Patient Inflammatory Responses Through Myeloid Cells
American Thoracic Society, 2023
Efzofitimod: A Novel Anti-Inflammatory Agent for Sarcoidosis
Baughman RP, Niranjan V, Walker G, Burkart C, Paz S, Chong YE, Siefker D, Sun E, Nangle L, Förster S, Muders MH, Farver CF, Lower EE, Shukla S, Culver DA.
Sarcoidosis, Vasculitis and Diffuse Lung Diseases (2023)
Inhibition of VEGF Binding to Neuropilin-2 Enhances Chemosensitivity and Inhibits Metastasis in Triple-Negative Breast Cancer
Xu Z, Goel HL, Burkart C, Burman L, Chong YE, Barber AG, Geng Y, Zhai L, Wang M, Kumar A, Menefee A, Polizzi C, Eide L, Rauch K, Rahman J, Hamel K, Fogassy K, Klopp-Savino S, Paz S, Zhang M, Cubitt A, Nangle LA, Mercurio AM.
Science Translational Medicine (2023)
Therapeutic Blocking of VEGF Binding to Neuropilin-2 Diminishes PD-L1 Expression to Activate Antitumor Immunity in Prostate Cancer
Wang M, Wisniewski CA, Xiong C, Chhoy P, Goel HL, Kumar A, Zhu LJ, Li R, St. Louis PA, Ferreira LM, Pakula H, Xu Z, Loda M, Jiang Z, Brehm MA, Mercurio AM.
Science Translational Medicine (2023)
Resistance to Cancer Therapy via Upregulation of the NRP2/VEGF-C Axis Can Be Neutralized By ATYR2810
American Association for Cancer Research, 2023